Introduction: Urticaria is a highly prevalent condition resulting in a large number of medical consultancies worldwide. Urticaria is derived from the Latin word “urere” meaning “to burn”. Urticaria usually manifests as a transient, itchy, polymorphic skin eruption. It can occur in any age group. Aim: To study the prevalence and possible triggers of acute urticaria in children. Materials and Methods: All children of age group six months to 12 years visiting the Institute from June 2018 to April 2019, with the complaint of acute urticaria with or without angioedema were included in the study while those with chronic urticaria and only angioedema were excluded. Sixty five children presented with acute urticaria with or without angioedema. Patients were diagnosed based on history and clinical examination. All patients were subjected to a detailed history, general physical examination and, necessary investigations like Complete Blood Count (CBC), absolute eosinophil count, Erythrocyte Sedimentation Rate (ESR), C-reactive Protein (CRP), Skin Prick test as indicated. They received appropriate treatment and their clinical outcome was studied. Results: Prevalence of acute urticaria was found to be 0.23. It was more commonly seen in males (63.08%) and more in the age group of 1 to 5 years (56.92%). The focus of infection was found in 44.6% of children, while 21% of children had a history of consumption of some form of medications leading to urticaria. Conclusion: Urticaria can be prevented in children by preventing them from infection and avoiding the use of amoxicillin-clavulanic acid unless very necessary. Those children with a family history of acute urticaria should be prevented from exposure to excessive heat, cold, pressure, vibration, etc. Investigations are also recommended as an important diagnostic tool to find out the aetiology of acute urticaria.

No abstract

Background: Evans syndrome is a rare autoimmune disorder characterized by simultaneous or sequential presence of a positive antiglobulin test, autoimmune haemolytic anemia (AIHA), and immune thrombocytopenia (ITP). It is characterised by frequent exacerbations and remissions within a chronic course. It was first described by Robert Evans in 1951.  Incidence of AIHA is 1 per 75 - 80,000 and ITP is 5.5 /100000 per general adult population.  Incidence of Evans syndrome is 1.8% to 10% of patients with ITP. Objective was to study the maternal and perinatal outcome of women with Evans syndrome (E).Methods: About 4 antenatal mothers were identified with Evans syndrome at St. Johns medical college and hospital, Bengaluru during the study period of 5 years from July 2013-July 2017. They were followed up during their antenatal, intra natal and postnatal period and outcomes were studied. All patients included in the study fulfilled the criteria for Evans syndrome.Results: There were 4 cases of Evans syndrome, with a total number of deliveries of 11859, during this 5 year study. Incidence was 0.09 per 1000 births. All patients presented with bleeding manifestations ranging from mucosal haemorrhage to subarachnoid haemorrhage (SAH) at the time of diagnosis. All patients were on treatment with either 1st or 2nd line of management with corticosteroids/ azathioprine. None had bleeding during pregnancy after the initiation of treatment. Patients had antenatal complications like preeclampsia 25%, IUGR 25%, oligohydraminos 50%, IUD 25%. 2 patients received platelet transfusions intrapartum. None had intrapartum or postpartum haemorrhage. There were no maternal and neonatal mortality.Conclusions: Evans syndrome in pregnancy is a rare condition and requires multi disciplinary approach involving specialists from obstetrics, neonatology, and hematology. Close maternal and fetal surveillance and management during pregnancy is essential to increase the possibility of a favourable pregnancy outcome in these women.